glp-1 hypoglycemia The impact of and incretin-based therapies on counterregulatory responses to in diabetes mellitus: mechanisms and clinical implications image2.png

Genistein protects against DSS-induced colitis by inhibiting NLRP3 inflammasome via TGR5-cAMP signaling

Derived from Gila monster, Heloderma suspectum, Exendin-4 has a longer half life than GLP-1 in the plasma, thus making it a more potent insulinotropic agent

In addition, melasma can be classified based on the depth of melanin

Switching between DAC and no-DAC mid-cycle

Compounding may be appropriate when: A required dose, concentration, or formulation is not commercially available An FDA-approved drug is in a temporary shortage A patient has a documented allergy or intolerance to an inactive ingredient Compounding is intended to address medical necessity , not convenience, mass substitution, or price alone